MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)
Hong Kong · Delayed Price · Currency is HKD 7.38
+0.15 (2.07%)
Feb 11, 2026, 3:06 PM HKT
HKG:2235 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 435.47 | 340.35 | 248.35 | 169.89 | 151.4 | 75.28 |
Other Revenue | 5.26 | 5.26 | 4.88 | 3.72 | - | - |
| 440.73 | 345.62 | 253.23 | 173.61 | 151.4 | 75.28 | |
Revenue Growth (YoY) | 50.30% | 36.48% | 45.86% | 14.67% | 101.13% | 45.15% |
Cost of Revenue | 215.18 | 166.54 | 136.08 | 93.91 | 80.52 | 38.73 |
Gross Profit | 225.56 | 179.08 | 117.14 | 79.69 | 70.88 | 36.54 |
Selling, General & Admin | 240.31 | 249.28 | 250.62 | 158.23 | 93.74 | 100.82 |
Research & Development | 74.57 | 76.56 | 70.1 | 61.09 | 36.08 | 82.01 |
Other Operating Expenses | 3.02 | -0.79 | -9.28 | -21.99 | - | - |
Operating Expenses | 321.23 | 326.49 | 312.43 | 200.04 | 131.05 | 183.01 |
Operating Income | -95.67 | -147.41 | -195.29 | -120.34 | -60.17 | -146.47 |
Interest Expense | -0.75 | -0.68 | -0.05 | -0.15 | -0.02 | -0.31 |
Interest & Investment Income | 60.92 | 64.25 | 68.24 | 55.72 | 24.49 | 8.14 |
Currency Exchange Gain (Loss) | 9.7 | 9.7 | 7.11 | 29.95 | -16.48 | -2.11 |
Other Non Operating Income (Expenses) | -8.94 | -0.3 | -4.68 | -0.22 | 3.97 | 19.26 |
EBT Excluding Unusual Items | -34.75 | -74.44 | -124.67 | -35.03 | -48.2 | -121.48 |
Gain (Loss) on Sale of Investments | -0.09 | 0.09 | -0.02 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | -0.01 | 0.05 | 0.23 |
Asset Writedown | -4.89 | -0.83 | -0.16 | -0 | - | - |
Other Unusual Items | 12.03 | 12.03 | 0 | - | - | - |
Pretax Income | -27.7 | -63.15 | -124.85 | -35.04 | -48.15 | -121.25 |
Income Tax Expense | -0.02 | -0.03 | 0.16 | 0 | - | - |
Earnings From Continuing Operations | -27.68 | -63.12 | -125.02 | -35.04 | -48.15 | -121.25 |
Minority Interest in Earnings | - | - | - | - | - | 0.24 |
Net Income | -27.68 | -63.12 | -125.02 | -35.04 | -48.15 | -121.01 |
Net Income to Common | -27.68 | -63.12 | -125.02 | -35.04 | -48.15 | -121.01 |
Shares Outstanding (Basic) | 418 | 418 | 431 | 438 | 373 | 306 |
Shares Outstanding (Diluted) | 418 | 418 | 431 | 438 | 373 | 306 |
Shares Change (YoY) | 2.34% | -3.05% | -1.59% | 17.39% | 21.79% | - |
EPS (Basic) | -0.07 | -0.15 | -0.29 | -0.08 | -0.13 | -0.39 |
EPS (Diluted) | -0.07 | -0.15 | -0.29 | -0.08 | -0.13 | -0.39 |
Free Cash Flow | -31.43 | -120.65 | -153 | -148.79 | -61.82 | -35.23 |
Free Cash Flow Per Share | -0.07 | -0.29 | -0.35 | -0.34 | -0.17 | -0.12 |
Gross Margin | 51.18% | 51.81% | 46.26% | 45.91% | 46.82% | 48.55% |
Operating Margin | -21.71% | -42.65% | -77.12% | -69.32% | -39.74% | -194.58% |
Profit Margin | -6.28% | -18.26% | -49.37% | -20.18% | -31.80% | -160.75% |
Free Cash Flow Margin | -7.13% | -34.91% | -60.42% | -85.71% | -40.83% | -46.80% |
EBITDA | -83.75 | -136.21 | -184.12 | -110.19 | -52.28 | -141.52 |
EBITDA Margin | -19.00% | -39.41% | -72.71% | -63.47% | -34.53% | -188.00% |
D&A For EBITDA | 11.93 | 11.2 | 11.17 | 10.15 | 7.88 | 4.95 |
EBIT | -95.67 | -147.41 | -195.29 | -120.34 | -60.17 | -146.47 |
EBIT Margin | -21.71% | -42.65% | -77.12% | -69.32% | -39.74% | -194.58% |
Revenue as Reported | 345.62 | 345.62 | 253.23 | 173.61 | - | - |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.